In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells
暂无分享,去创建一个
S. Pillai | J. Wong | M. Strain | C. Ignacio | S. Dandekar | R. Porrata | D. Looney | E. Reay | S. Sankaran-Walters | T. Russell | Satya Dandekar | Joseph K. Wong | Matthew C. Strain | Rodin Porrata | Elizabeth Reay | Sumathi Sankaran-Walters | Caroline C. Ignacio | Theresa Russell | Satish K. Pillai | David J. Looney | Sumathi Sankaran-Walters
[1] Michael D. George,et al. Early Antiretroviral Therapy for Simian Immunodeficiency Virus Infection Leads to Mucosal CD4+ T-Cell Restoration and Enhanced Gene Expression Regulating Mucosal Repair and Regeneration , 2005, Journal of Virology.
[2] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[3] L M Wahl,et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.
[4] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[5] J. Levy,et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.
[6] Christine Hogan,et al. Determining the relative efficacy of highly active antiretroviral therapy. , 2003, The Journal of infectious diseases.
[7] D. Montefiori,et al. Effect of Humoral Immune Responses on Controlling Viremia during Primary Infection of Rhesus Monkeys with Simian Immunodeficiency Virus , 2003, Journal of Virology.
[8] Eun-Young Kim,et al. Contribution of CD8+ T Cells to Containment of Viral Replication and Emergence of Mutations in Mamu-A*01-Restricted Epitopes in Simian Immunodeficiency Virus-Infected Rhesus Monkeys , 2008, Journal of Virology.
[9] A. Perelson,et al. Short-Lived Infected Cells Support Virus Replication in Sooty Mangabeys Naturally Infected with Simian Immunodeficiency Virus: Implications for AIDS Pathogenesis , 2008, Journal of Virology.
[10] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[11] N. Pedersen,et al. Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. , 2001, AIDS research and human retroviruses.
[12] D. Watkins,et al. Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.
[13] D. Baltimore,et al. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression , 1989, Journal of virology.
[14] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[15] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[16] D. Montefiori,et al. Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques , 2005, Journal of Virology.
[17] J. Levy,et al. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. , 1989, Immunology.
[18] Michael S Saag,et al. Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline , 2008, AIDS.
[19] D. Baltimore,et al. HIV's evasion of the cellular immune response , 1999, Immunological reviews.
[20] S. Staprans,et al. bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on March 1, 2013. For personal use , 2006 .
[21] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[22] M. Nei,et al. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.
[23] J. Moore,et al. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1 , 1994, Journal of virology.
[24] L. Picker,et al. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, The Journal of experimental medicine.
[25] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[26] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[27] D. Baltimore,et al. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] H. Günthard,et al. Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Do Not Predict Viral Growth and Clearance Rates during Structured Intermittent Antiretroviral Therapy , 2002, Journal of Virology.
[29] L M Wahl,et al. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Altfeld,et al. NK cell function in HIV-1 infection. , 2006, Current molecular medicine.
[31] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[32] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[33] Anthony S Fauci,et al. An HIV vaccine--challenges and prospects. , 2008, The New England journal of medicine.
[34] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[35] Alan S. Perelson,et al. CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells , 2010, PLoS pathogens.
[36] Anthony S Fauci,et al. An HIV vaccine--evolving concepts. , 2007, The New England journal of medicine.
[37] J. Levy,et al. HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. , 1992, Clinical immunology and immunopathology.
[38] S. Dandekar,et al. Antiviral Therapy during Primary Simian Immunodeficiency Virus Infection Fails To Prevent Acute Loss of CD4+ T Cells in Gut Mucosa but Enhances Their Rapid Restoration through Central Memory T Cells , 2008, Journal of Virology.
[39] H. Clifford Lane,et al. Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.
[40] J. Safrit,et al. Depletion of CD8+ Cells in Sooty Mangabey Monkeys Naturally Infected with Simian Immunodeficiency Virus Reveals Limited Role for Immune Control of Virus Replication in a Natural Host Species1 , 2007, The Journal of Immunology.
[41] R. Sékaly. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.
[42] H. Günthard,et al. Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes , 2007, Journal of Virology.
[43] A. Trkola,et al. Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection , 2006, PLoS medicine.